ResearcherEndeavor HealthNo recent work listed
Sung Hoon Choi
Matched on ORCID iD 0000-0002-1664-3727; OpenAlex author ID A5017969274. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper
Papers 7
- Extended postoperative thromboprophylaxis after pancreatic resection for pancreatic cancer is associated with decreased risk of venous thromboembolism in the m… Co-author DOI 10.1002/jso.27135↗
- Oncologic Impact of Local Recurrence in Resected Pancreatic Cancer and Topographic Preference in Local Recurrence Patterns According to Tumor Location. Co-author DOI 10.1097/mpa.0000000000001679↗
- The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular Involvement. Co-author DOI 10.1097/md.0000000000001233↗
- Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria: long-term (>median 3 years) oncologic outcomes. Co-author DOI 10.1007/s00464-014-3537-3↗
- Controversial issues of neoadjuvant treatment in borderline resectable pancreatic cancer. Co-author DOI 10.1016/j.suronc.2013.02.007↗
- Robotic anterior RAMPS in well-selected left-sided pancreatic cancer. Co-author DOI 10.1007/s11605-012-1825-6↗
- Multimedia article. Laparoscopic modified anterior RAMPS in well-selected left-sided pancreatic cancer: technical feasibility and interim results. Co-author DOI 10.1007/s00464-010-1556-2↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chang Moo Kang · 6 shared papers, 2011–2020 · strength 0.38
- Paper Oncologic Impact of Local Recurrence in Resected Pancreatic Cancer and Topographic Preference in Local Recurrence Patte… DOI 10.1097/mpa.0000000000001679↗
- Paper The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated V… DOI 10.1097/md.0000000000001233↗
- Paper Controversial issues of neoadjuvant treatment in borderline resectable pancreatic cancer. DOI 10.1016/j.suronc.2013.02.007↗
- Woo Jung Lee · 6 shared papers, 2011–2020 · strength 0.38
- Paper Oncologic Impact of Local Recurrence in Resected Pancreatic Cancer and Topographic Preference in Local Recurrence Patte… DOI 10.1097/mpa.0000000000001679↗
- Paper The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated V… DOI 10.1097/md.0000000000001233↗
- Paper Controversial issues of neoadjuvant treatment in borderline resectable pancreatic cancer. DOI 10.1016/j.suronc.2013.02.007↗
- Ho Kyoung Hwang · 5 shared papers, 2012–2020 · strength 0.34
- Paper Oncologic Impact of Local Recurrence in Resected Pancreatic Cancer and Topographic Preference in Local Recurrence Patte… DOI 10.1097/mpa.0000000000001679↗
- Paper The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated V… DOI 10.1097/md.0000000000001233↗
- Paper Controversial issues of neoadjuvant treatment in borderline resectable pancreatic cancer. DOI 10.1016/j.suronc.2013.02.007↗
- Melissa Ellen Hogg · 1 shared paper, 2023 · strength 0.18
- Divya Sood · 1 shared paper, 2023 · strength 0.18
- Marina Talamonti · 1 shared paper, 2023 · strength 0.18
- Hoon Sang Chi · 3 shared papers, 2011–2014 · strength 0.13
- Paper Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria: long-term (>median 3 yea… DOI 10.1007/s00464-014-3537-3↗
- Paper Robotic anterior RAMPS in well-selected left-sided pancreatic cancer. DOI 10.1007/s11605-012-1825-6↗
- Paper Multimedia article. Laparoscopic modified anterior RAMPS in well-selected left-sided pancreatic cancer: technical feasi… DOI 10.1007/s00464-010-1556-2↗
- Jin Ho Lee · 1 shared paper, 2015 · strength 0.05
- Seungmin Bang · 1 shared paper, 2015 · strength 0.05
- Sung Hwan Lee · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.